Pleural effusion, the accumulation of fluid within the pleural space, can result from a variety of conditions, including heart failure, infections, malignancies, and inflammatory diseases. Pleural effusion management requires accurate diagnosis, identification of the underlying cause, and timely intervention to relieve symptoms and prevent complications. Initial evaluation typically involves imaging studies such as chest X-rays, ultrasound, or computed tomography, along with thoracentesis for fluid analysis to determine etiology. Management strategies include both conservative and interventional approaches, depending on the severity, rate of fluid accumulation, and underlying pathology. Therapeutic options may include diuretics, antibiotics, or anti-inflammatory medications for fluid control, as well as procedures such as thoracentesis, chest tube drainage, or pleurodesis in cases of recurrent or large effusions. Pleural effusion management also emphasizes close monitoring of respiratory function, oxygenation, and patient comfort, as fluid accumulation can compromise lung expansion and lead to dyspnea. Multidisciplinary collaboration among pulmonologists, radiologists, thoracic surgeons, and critical care teams ensures comprehensive care and minimizes risk of recurrence or complications. Advances in minimally invasive techniques and imaging-guided interventions have improved procedural safety and outcomes, while research continues to explore novel therapies for complex or malignant effusions. By combining accurate diagnosis, targeted treatment, and supportive care, effective pleural effusion management enhances patient quality of life, prevents respiratory compromise, and addresses the underlying disease process.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation